Saniona förstärker ledningsgruppen genom utnämningar av Chief Financial Officer, Chief Communications Officer och Chief Human Resources Officer

    NEXT STORY
    Press Release Oncology Venture’s Novel PARP Inhibitor Stenoparib (formerly 2X-121) Shows Anti-Viral Activity Against Coronavirus in Pre-Clinical Studies
    PREV STORY
    Novartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase III chronic myeloid leukemia study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin

    author_avatar
    NASDAQ Market News

    Bavarian Nordic to Host Capital Markets Day in New York City

    COPENHAGEN, Denmark, September 14, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will ...

    author_avatar
    NASDAQ Market News

    Ascendis Pharma A/S Announces Presentations on Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences

    COPENHAGEN, Denmark, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News